Clinical Trial: Safety and Suitability of Supplementing Early MIP Surgery (MIPS) of ICH With Pioglitazone
Study Status: Completed
Recruit Status: RECRUITING
Condition: Intracerebral Haemorrhage, Intraventricular
Study Type: INTERVENTIONAL
Official Title: A Non-Randomized Controlled Trial to Examine the Safety and Suitability of Supplementing Early Minimally Invasive Parafascicular Surgery (MIPS) for Clot Evacuation of Basal Ganglia Intracerebral Hemor
Brief Summary:
This is an exploratory single-center prospective study of 20 subjects with primary basal ganglia ICH who will receive early MIPS in combination with perioperative pioglitazone treatment.Outcomes will be compared to matched subjects with basal ganglia ICH who undergo MIPS alone as part of the ENRICH trial.This study will take approximately two years to complete.
Read more